- Correction
- Open access
- Published:
Correction: TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer
Journal of Experimental & Clinical Cancer Research volume 43, Article number: 244 (2024)
Correction: J Exp Clin Cancer Res 43, 219 (2024)
https://doi.org/10.1186/s13046-024-03142-4
Following publication of the original article [1], the authors found out errors pertaining on the affiliations of the authors. The changes requested are highlighted in bold.
• Affiliation 2 should be changed from: “IRCCS Candiolo Cancer Institute, Candiolo, Italy” to “Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy”.
• Affiliation 5 should be updated from: “Department of Pharmacy, University of Napoli “Federico II”, Napoli, Italy” to “Department of Pharmacy, University of Napoli Federico II, Napoli, Italy”.
• Affiliation 7 should be updated from: “Medical University of Vienna, Vienna, Austria” to “Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria”.
These corrections do not affect the overall result or conclusion of the article. The original article [1] has been corrected.
References
Akman M, Monteleone C, Doronzo G, et al. TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer. J Exp Clin Cancer Res. 2024;43:219. https://doi.org/10.1186/s13046-024-03142-4.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s13046-024-03142-4.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Akman, M., Monteleone, C., Doronzo, G. et al. Correction: TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer. J Exp Clin Cancer Res 43, 244 (2024). https://doi.org/10.1186/s13046-024-03170-0
Published:
DOI: https://doi.org/10.1186/s13046-024-03170-0